{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:51:40Z","timestamp":1792050700020,"version":"4.4.0"},"reference-count":75,"publisher":"American Association for Cancer Research (AACR)","issue":"20","funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2021-NR059767"],"award-info":[{"award-number":["RS-2021-NR059767"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00222687"],"award-info":[{"award-number":["RS-2023-00222687"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00405619"],"award-info":[{"award-number":["RS-2024-00405619"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2024-00439165"],"award-info":[{"award-number":["RS-2024-00439165"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"publisher","award":["800-20200510"],"award-info":[{"award-number":["800-20200510"]}],"id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00412332"],"award-info":[{"award-number":["RS-2024-00412332"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>KRAS mutations, present in about 40% of colorectal cancers, are strongly associated with an immunosuppressive tumor microenvironment characterized by restricted immune infiltration and poor responses to immunotherapy. In this study, we found that KRAS mutations remodel the N6-methyladenosine (m6A) epitranscriptome to promote immune evasion. Methylated RNA immunoprecipitation sequencing revealed that KRAS-mutant cells exhibit increased m6A deposition on CD73 mRNA, enhancing its stability through IGF2BP3. TEAD4-dependent recruitment of the METTL3 methyltransferase complex induced the m6A modification, identifying TEAD4 as a spatial regulator of m6A deposition. Functionally, METTL3 knockdown in KRAS-mutant syngeneic tumors suppressed tumor growth and restored antitumor immunity by increasing CD8+ T-cell and NK cell infiltration in a CD73-dependent manner. Moreover, METTL3 inhibition synergized with anti\u2013PD-1 therapy and a CD73 inhibitor to reduce tumor burden. Together, these findings demonstrate that KRAS-driven m6A remodeling is a key mechanism of immune suppression in colorectal cancer and highlight METTL3 as a promising therapeutic target.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>KRAS mutations suppress immune cell infiltration by increasing CD73 expression through m6A reprogramming driven by TEAD4-mediated relocalization of METTL3, providing a targetable axis to promote antitumor immunity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-26-0403","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:20:54Z","timestamp":1785356454000},"page":"5184-5204","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["<i>KRAS<\/i>\n                    Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer"],"prefix":"10.1158","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6599-8325","authenticated-orcid":false,"given":"Seungjae","family":"Shin","sequence":"first","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6033-290X","authenticated-orcid":false,"given":"Seung-Pyo","family":"Hong","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."},{"name":"2Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3167-0492","authenticated-orcid":false,"given":"Seoho","family":"Lee","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4245-4605","authenticated-orcid":false,"given":"Yeonseo","family":"Jang","sequence":"additional","affiliation":[{"name":"3Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1505-7619","authenticated-orcid":false,"given":"Jisoo","family":"Yang","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6863-4590","authenticated-orcid":false,"given":"Jaeik","family":"Oh","sequence":"additional","affiliation":[{"name":"2Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5140-6221","authenticated-orcid":false,"given":"Dongjun","family":"Jang","sequence":"additional","affiliation":[{"name":"2Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5520-6522","authenticated-orcid":false,"given":"Soo-Jin","family":"Lee","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7247-3868","authenticated-orcid":false,"given":"Jiwon","family":"Kim","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7636-9432","authenticated-orcid":false,"given":"Sang Eun","family":"Lee","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0045-8484","authenticated-orcid":false,"given":"Yoojin","family":"Yang","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1569-0146","authenticated-orcid":false,"given":"Dohee","family":"Kim","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7235-8987","authenticated-orcid":false,"given":"Eunjeong","family":"Yang","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8875-4269","authenticated-orcid":false,"given":"Seohyeon","family":"Park","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3850-6096","authenticated-orcid":false,"given":"Sabeen","family":"Hwang","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9215-9602","authenticated-orcid":false,"given":"Ae Jin","family":"Choi","sequence":"additional","affiliation":[{"name":"2Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8307-2474","authenticated-orcid":false,"given":"Hae Rim","family":"Jung","sequence":"additional","affiliation":[{"name":"2Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5993-1254","authenticated-orcid":false,"given":"Yumi","family":"Oh","sequence":"additional","affiliation":[{"name":"2Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7156-4423","authenticated-orcid":false,"given":"Chang-Han","family":"Lee","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."},{"id":[{"id":"https:\/\/ror.org\/04h9pn542","id-type":"ROR","asserted-by":"publisher"}],"name":"Seoul National University 4 Cancer Research Institute, , Seoul, Republic of Korea."},{"name":"5BK21 FOUR Biomedical Science Project, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-8273","authenticated-orcid":false,"given":"Joo-Youn","family":"Cho","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."},{"name":"3Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1635-173X","authenticated-orcid":false,"given":"Kyungho","family":"Choi","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."},{"id":[{"id":"https:\/\/ror.org\/04h9pn542","id-type":"ROR","asserted-by":"publisher"}],"name":"Seoul National University 4 Cancer Research Institute, , Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0462-3072","authenticated-orcid":false,"given":"Jeong Mo","family":"Bae","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04h9pn542","id-type":"ROR","asserted-by":"publisher"}],"name":"Seoul National University 4 Cancer Research Institute, , Seoul, Republic of Korea."},{"name":"6Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7240-3744","authenticated-orcid":false,"given":"Jong-Il","family":"Kim","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."},{"name":"2Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Republic of Korea."},{"id":[{"id":"https:\/\/ror.org\/04h9pn542","id-type":"ROR","asserted-by":"publisher"}],"name":"Seoul National University 4 Cancer Research Institute, , Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2720-6952","authenticated-orcid":false,"given":"Sung-Yup","family":"Cho","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea."},{"name":"2Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Republic of Korea."},{"id":[{"id":"https:\/\/ror.org\/04h9pn542","id-type":"ROR","asserted-by":"publisher"}],"name":"Seoul National University 4 Cancer Research Institute, , Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"2026101503083994300_bib1","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.molmed.2023.03.007","article-title":"Cancer driver mutations: predictions and reality","volume":"29","author":"Ostroverkhova","year":"2023","journal-title":"Trends Mol Med"},{"key":"2026101503083994300_bib2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12943-021-01441-4","article-title":"Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer","volume":"20","author":"Zhu","year":"2021","journal-title":"Mol Cancer"},{"key":"2026101503083994300_bib3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026101503083994300_bib4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/s1535-6108(04)00085-6","article-title":"Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects","volume":"5","author":"Tuveson","year":"2004","journal-title":"Cancer Cell"},{"key":"2026101503083994300_bib5","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1038\/emm.2014.99","article-title":"Activation of KRAS promotes the mesenchymal features of basal-type breast cancer","volume":"47","author":"Kim","year":"2015","journal-title":"Exp Mol Med"},{"key":"2026101503083994300_bib6","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1038\/s41467-020-19288-6","article-title":"Immune modulatory effects of oncogenic KRAS in cancer","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Nat Commun"},{"key":"2026101503083994300_bib7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2026101503083994300_bib8","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-06-0191","article-title":"KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer","volume":"66","author":"Li\u00e8vre","year":"2006","journal-title":"Cancer Res"},{"key":"2026101503083994300_bib9","doi-asserted-by":"publisher","first-page":"5962","DOI":"10.1158\/1078-0432.CCR-20-2077","article-title":"Epithelial-to-mesenchymal transition is a cause of both intrinsic and acquired resistance to KRAS G12C inhibitor in KRAS G12C-mutant non-small cell lung cancer","volume":"26","author":"Adachi","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2026101503083994300_bib10","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.jtho.2021.04.015","article-title":"KRAS secondary mutations that confer acquired resistance to KRAS G12C inhibitors, sotorasib and adagrasib, and overcoming strategies: insights from in vitro experiments","volume":"16","author":"Koga","year":"2021","journal-title":"J Thorac Oncol"},{"key":"2026101503083994300_bib11","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","article-title":"Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers","volume":"74","author":"Shi","year":"2019","journal-title":"Mol Cell"},{"key":"2026101503083994300_bib12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","article-title":"The roles and implications of RNA m6A modification in cancer","volume":"20","author":"Deng","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"2026101503083994300_bib13","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1016\/j.molcel.2021.06.023","article-title":"m6A RNA methylation regulates promoter- proximal pausing of RNA polymerase II","volume":"81","author":"Akhtar","year":"2021","journal-title":"Mol Cell"},{"key":"2026101503083994300_bib14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature24678","article-title":"Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nature"},{"key":"2026101503083994300_bib15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nature25784","article-title":"The SMAD2\/3 interactome reveals that TGF\u03b2 controls m6A mRNA methylation in pluripotency","volume":"555","author":"Bertero","year":"2018","journal-title":"Nature"},{"key":"2026101503083994300_bib16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41586-019-1016-7","article-title":"Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally","volume":"567","author":"Huang","year":"2019","journal-title":"Nature"},{"key":"2026101503083994300_bib17","first-page":"1443","article-title":"METTL3 regulates alternative splicing of cell cycle-related genes via crosstalk between mRNA m6A modifications and splicing factors","volume":"13","author":"Kim","year":"2023","journal-title":"Am J Cancer Res"},{"key":"2026101503083994300_bib18","doi-asserted-by":"publisher","first-page":"100724","DOI":"10.1016\/j.xpro.2021.100724","article-title":"Quantitative analysis of m6A RNA modification by LC-MS","volume":"2","author":"Mathur","year":"2021","journal-title":"STAR Protoc"},{"key":"2026101503083994300_bib19","doi-asserted-by":"publisher","first-page":"e61841","DOI":"10.7554\/eLife.61841","article-title":"Induction of the IL-1RII decoy receptor by NFAT\/FOXP3 blocks IL-1\u03b2-dependent response of Th17 cells","volume":"10","author":"Kim","year":"2021","journal-title":"Elife"},{"key":"2026101503083994300_bib20","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1158\/1078-0432.CCR-18-3460","article-title":"Unstable genome and transcriptome dynamics during tumor metastasis contribute to therapeutic heterogeneity in colorectal cancers","volume":"25","author":"Cho","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2026101503083994300_bib21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","article-title":"Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer","volume":"52","author":"Lee","year":"2020","journal-title":"Nat Genet"},{"key":"2026101503083994300_bib22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41467-020-20379-7","article-title":"EGFR\/SRC\/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma","volume":"12","author":"Fang","year":"2021","journal-title":"Nat Commun"},{"key":"2026101503083994300_bib23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.molcel.2020.10.026","article-title":"Stabilization of ERK-phosphorylated METTL3 by USP5 increases m6A methylation","volume":"80","author":"Sun","year":"2020","journal-title":"Mol Cell"},{"key":"2026101503083994300_bib24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41467-017-02391-6","article-title":"Perturbation-response genes reveal signaling footprints in cancer gene expression","volume":"9","author":"Schubert","year":"2018","journal-title":"Nat Commun"},{"key":"2026101503083994300_bib25","doi-asserted-by":"publisher","first-page":"113042","DOI":"10.1016\/j.celrep.2023.113042","article-title":"Ectopic expression of DOCK8 regulates lysosome-mediated pancreatic tumor cell invasion","volume":"42","author":"Gutierrez-Ruiz","year":"2023","journal-title":"Cell Rep"},{"key":"2026101503083994300_bib26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","article-title":"Notch signaling pathway in cancer: from mechanistic insights to targeted therapies","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"2026101503083994300_bib27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ccell.2024.02.012","article-title":"Exploiting the therapeutic implications of KRAS inhibition on tumor immunity","volume":"42","author":"Molina-Arcas","year":"2024","journal-title":"Cancer Cell"},{"key":"2026101503083994300_bib28","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc.2017.86","article-title":"Targeting immunosuppressive adenosine in cancer","volume":"17","author":"Vijayan","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"2026101503083994300_bib29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","article-title":"CD39\/CD73\/A2AR pathway and cancer immunotherapy","volume":"22","author":"Xia","year":"2023","journal-title":"Mol Cancer"},{"key":"2026101503083994300_bib30","doi-asserted-by":"publisher","first-page":"D194","DOI":"10.1093\/nar\/gkad691","article-title":"m6A-Atlas v2.0: updated resources for unraveling the N6-methyladenosine (m6A) epitranscriptome among multiple species","volume":"52","author":"Liang","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026101503083994300_bib31","doi-asserted-by":"publisher","first-page":"7361","DOI":"10.1093\/nar\/gkab517","article-title":"Epitranscriptomic editing of the RNA N6-methyladenosine modification by dCasRx conjugated methyltransferase and demethylase","volume":"49","author":"Xia","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2026101503083994300_bib32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat Cell Biol"},{"key":"2026101503083994300_bib33","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/s41588-022-01173-1","article-title":"RNA m6A regulates transcription via DNA demethylation and chromatin accessibility","volume":"54","author":"Deng","year":"2022","journal-title":"Nat Genet"},{"key":"2026101503083994300_bib34","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.molcel.2022.04.010","article-title":"The Mettl3 epitranscriptomic writer amplifies p53 stress responses","volume":"82","author":"Raj","year":"2022","journal-title":"Mol Cell"},{"key":"2026101503083994300_bib35","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1158\/0008-5472.CAN-17-0395","article-title":"MAPK signaling and inflammation link melanoma phenotype switching to induction of CD73 during immunotherapy","volume":"77","author":"Reinhardt","year":"2017","journal-title":"Cancer Res"},{"key":"2026101503083994300_bib36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.gpb.2019.09.006","article-title":"hTFtarget: a comprehensive database for regulations of human transcription factors and their targets","volume":"18","author":"Zhang","year":"2020","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"2026101503083994300_bib37","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1002\/j.1460-2075.1993.tb06204.x","article-title":"Activation of ternary complex factor Elk-1 by MAP kinases","volume":"12","author":"Janknecht","year":"1993","journal-title":"EMBO J"},{"key":"2026101503083994300_bib38","doi-asserted-by":"publisher","first-page":"ra42","DOI":"10.1126\/scisignal.2005049","article-title":"Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma","volume":"7","author":"Zhang","year":"2014","journal-title":"Sci Signal"},{"key":"2026101503083994300_bib39","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1002\/1878-0261.12999","article-title":"Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1","volume":"15","author":"Kandasamy","year":"2021","journal-title":"Mol Oncol"},{"key":"2026101503083994300_bib40","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein-protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat Protoc"},{"key":"2026101503083994300_bib41","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/carcin\/bgt409","article-title":"Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer","volume":"35","author":"Lim","year":"2014","journal-title":"Carcinogenesis"},{"key":"2026101503083994300_bib42","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41556-021-00656-3","article-title":"m6A-independent genome-wide METTL3 and METTL14 redistribution drives the senescence-associated secretory phenotype","volume":"23","author":"Liu","year":"2021","journal-title":"Nat Cell Biol"},{"key":"2026101503083994300_bib43","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/ncb3216","article-title":"Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth","volume":"17","author":"Zanconato","year":"2015","journal-title":"Nat Cell Biol"},{"key":"2026101503083994300_bib44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41698-018-0049-y","article-title":"Interaction between Wnt\/\u03b2-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of \u03b2-catenin and RAS by targeting the Wnt\/\u03b2-catenin pathway","volume":"2","author":"Jeong","year":"2018","journal-title":"NPJ Precis Oncol"},{"key":"2026101503083994300_bib45","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1126\/science.1204831","article-title":"Control of mitotic spindle angle by the RAS-regulated ERK1\/2 pathway determines lung tube shape","volume":"333","author":"Tang","year":"2011","journal-title":"Science"},{"key":"2026101503083994300_bib46","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"2026101503083994300_bib47","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1172\/JCI128895","article-title":"CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment","volume":"130","author":"Neo","year":"2020","journal-title":"J Clin Invest"},{"key":"2026101503083994300_bib48","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ccell.2016.06.025","article-title":"Co-inhibition of CD73 and A2AR adenosine signaling improves anti-tumor immune responses","volume":"30","author":"Young","year":"2016","journal-title":"Cancer Cell"},{"key":"2026101503083994300_bib49","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.gastro.2022.06.024","article-title":"METTL3 inhibits antitumor immunity by targeting m6A-BHLHE41-CXCL1\/CXCR2 axis to promote colorectal cancer","volume":"163","author":"Chen","year":"2022","journal-title":"Gastroenterology"},{"key":"2026101503083994300_bib50","doi-asserted-by":"publisher","first-page":"e104514","DOI":"10.15252\/embj.2020104514","article-title":"m6 A RNA methyltransferases METTL3\/14 regulate immune responses to anti-PD-1 therapy","volume":"39","author":"Wang","year":"2020","journal-title":"EMBO J"},{"key":"2026101503083994300_bib51","doi-asserted-by":"publisher","first-page":"6860","DOI":"10.1021\/acs.jmedchem.4c02151","article-title":"Development of CD73 inhibitors in tumor immunotherapy and opportunities in imaging and combination therapy","volume":"68","author":"Bi","year":"2025","journal-title":"J Med Chem"},{"key":"2026101503083994300_bib52","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/s41591-026-04283-z","article-title":"Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial","volume":"32","author":"Wainberg","year":"2026","journal-title":"Nat Med"},{"key":"2026101503083994300_bib53","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","article-title":"CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics","volume":"20","author":"Jin","year":"2025","journal-title":"Nat Protoc"},{"key":"2026101503083994300_bib54","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41467-021-21099-2","article-title":"Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy","volume":"12","author":"Yang","year":"2021","journal-title":"Nat Commun"},{"key":"2026101503083994300_bib55","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.4049\/jimmunol.1102152","article-title":"Role of macrophage migration inhibitory factor in the regulatory T cell response of tumor-bearing mice","volume":"189","author":"Choi","year":"2012","journal-title":"J Immunol"},{"key":"2026101503083994300_bib56","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.4049\/jimmunol.1201650","article-title":"Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor","volume":"190","author":"Yaddanapudi","year":"2013","journal-title":"J Immunol"},{"key":"2026101503083994300_bib57","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ccell.2023.01.001","article-title":"Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"2026101503083994300_bib58","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41586-024-07352-w","article-title":"PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function","volume":"629","author":"Morotti","year":"2024","journal-title":"Nature"},{"key":"2026101503083994300_bib59","doi-asserted-by":"publisher","first-page":"0013","DOI":"10.34133\/cancomm.0013","article-title":"CEBPB expression in tumor cells drives immune evasion in colorectal cancer via CTLA4 up-regulation in T cells","volume":"46","author":"Yun","year":"2026","journal-title":"Cancer Commun (Lond)"},{"key":"2026101503083994300_bib60","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.21873\/anticanres.14880","article-title":"CD73 is regulated by the EGFR-ERK signaling pathway in non-small cell lung cancer","volume":"41","author":"Griesing","year":"2021","journal-title":"Anticancer Res"},{"key":"2026101503083994300_bib61","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.str.2021.05.001","article-title":"Structures and target RNA preferences of the RNA-binding protein family of IGF2BPs: an overview","volume":"29","author":"Korn","year":"2021","journal-title":"Structure"},{"key":"2026101503083994300_bib62","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/0008-5472.CAN-21-2988","article-title":"EIF4A3-induced circARHGAP29 promotes aerobic glycolysis in docetaxel-resistant prostate cancer through IGF2BP2\/c-Myc\/LDHA signaling","volume":"82","author":"Jiang","year":"2022","journal-title":"Cancer Res"},{"key":"2026101503083994300_bib63","doi-asserted-by":"publisher","first-page":"113024","DOI":"10.1016\/j.yexcr.2022.113024","article-title":"FOXP3 activated-LINC01232 accelerates the stemness of non-small cell lung carcinoma by activating TGF-beta signaling pathway and recruiting IGF2BP2 to stabilize TGFBR1","volume":"413","author":"Zhu","year":"2022","journal-title":"Exp Cell Res"},{"key":"2026101503083994300_bib64","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1038\/s41467-022-32963-0","article-title":"Autophagy induction promoted by m6A reader YTHDF3 through translation upregulation of FOXO3 mRNA","volume":"13","author":"Hao","year":"2022","journal-title":"Nat Commun"},{"key":"2026101503083994300_bib65","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41392-020-00453-8","article-title":"HIF-1\u03b1-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2026101503083994300_bib66","doi-asserted-by":"publisher","first-page":"E2047","DOI":"10.1073\/pnas.1602883113","article-title":"Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA","volume":"113","author":"Zhang","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026101503083994300_bib67","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cell.2014.06.003","article-title":"Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer","volume":"158","author":"Kapoor","year":"2014","journal-title":"Cell"},{"key":"2026101503083994300_bib68","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1158\/1078-0432.CCR-19-0081","article-title":"Mobilization of CD8+ T cells via CXCR4 blockade facilitates PD-1 checkpoint therapy in human pancreatic cancer","volume":"25","author":"Seo","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2026101503083994300_bib69","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41467-019-14259-y","article-title":"HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors","volume":"11","author":"Song","year":"2020","journal-title":"Nat Commun"},{"key":"2026101503083994300_bib70","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s13046-023-02861-4","article-title":"Paracrine activin B-NF-\u03baB signaling shapes an inflammatory tumor microenvironment in gastric cancer via fibroblast reprogramming","volume":"42","author":"Jin","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"2026101503083994300_bib71","doi-asserted-by":"publisher","first-page":"10259","DOI":"10.1038\/s41467-024-54710-3","article-title":"Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients","volume":"15","author":"Feng","year":"2024","journal-title":"Nat Commun"},{"key":"2026101503083994300_bib72","doi-asserted-by":"publisher","first-page":"e70004","DOI":"10.1002\/mog2.70004","article-title":"WNT2 blockade augments antitumor immunity by attenuating myeloid-derived suppressor cells in colorectal cancer","volume":"3","author":"Cui","year":"2024","journal-title":"Medcomm-Oncol"},{"key":"2026101503083994300_bib73","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S1470-2045(22)00197-8","article-title":"Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study","volume":"23","author":"Diaz","year":"2022","journal-title":"Lancet Oncol"},{"key":"2026101503083994300_bib74","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s12672-025-04001-0","article-title":"Cancer immunotherapy by adenosinergic CD39 and CD73 as emerging immune checkpoints","volume":"16","author":"Yin","year":"2025","journal-title":"Discov Oncol"},{"key":"2026101503083994300_bib75","doi-asserted-by":"publisher","first-page":"e2410806","DOI":"10.1002\/advs.202410806","article-title":"RNA N6-methyladenosine-binding protein YTHDFs redundantly attenuate cancer immunity by downregulating IFN-\u03b3 signaling in gastric cancer","volume":"12","author":"Jang","year":"2025","journal-title":"Adv Sci (Weinh)"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-26-0403\/3817866\/can-26-0403.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-26-0403\/3825409\/can-26-0403.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/20\/5184\/3836948\/can-26-0403.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/20\/5184\/3836948\/can-26-0403.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:08:47Z","timestamp":1792048127000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/86\/20\/5184\/788689\/KRAS-Mutations-Reprogram-RNA-m6A-Modifications-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":75,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2026,7,29]]},"published-print":{"date-parts":[[2026,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-26-0403","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.34520261","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520240","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520273","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520264","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520231","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520276","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520243","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520222","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520255","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520234","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520267","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520246","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520258","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520225","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.34520249","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.8775281","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}